Cross-recognition of HLA DR4 alloantigen by virus-specific CD8+ T cells: a new paradigm for self-/nonself-recognition.
暂无分享,去创建一个
[1] L. Gerber,et al. Human lymphocyte antigens characterizing psoriatic arthritis and its subtypes. , 1982, The Journal of rheumatology.
[2] D. Gladman,et al. HLA antigens in psoriatic arthritis. , 1986, The Journal of rheumatology.
[3] P. Cresswell,et al. Impaired assembly and transport of HLA‐A and ‐B antigens in a mutant TxB cell hybrid. , 1986, The EMBO journal.
[4] P. Gregersen,et al. Molecular diversity of HLA-DR4 haplotypes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[5] R. Palmiter,et al. The effect of thymus environment on T cell development and tolerance , 1988, Cell.
[6] S. Jameson,et al. Selective development of CD4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptor , 1989, Nature.
[7] M. Bevan,et al. Role of self-peptides in positively selecting the T-cell repertoire , 1990, Nature.
[8] A. Rudensky,et al. On the complexity of self , 1991, Nature.
[9] L. Steinman,et al. Analysis of the T cell repertoire using the PCR and specific oligonucleotide primers. , 1992, BioTechniques.
[10] E. Kieff,et al. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development , 1992, The Journal of experimental medicine.
[11] M F del Guercio,et al. HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions. , 1993, Journal of immunology.
[12] C. Janeway,et al. Thymic selection: two pathways to life and two to death. , 1994, Immunity.
[13] C. Eastmond. Psoriatic arthritis. Genetics and HLA antigens. , 1994, Bailliere's clinical rheumatology.
[14] Kristin A. Hogquist,et al. T cell receptor antagonist peptides induce positive selection , 1994, Cell.
[15] P. Doherty,et al. CD8+ T-cell memory to viruses. , 1994, Current opinion in immunology.
[16] C. Eastmond. Genetics and HLA antigens , 1994 .
[17] J. Burrows,et al. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease , 1994, The Journal of experimental medicine.
[18] A. Rolink,et al. Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor , 1994, The Journal of experimental medicine.
[19] R. Karr,et al. Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association , 1995, The Journal of experimental medicine.
[20] D. Zaller,et al. Lyme disease in human DR4Dw4-transgenic mice. , 1995, The Journal of infectious diseases.
[21] H. Ishibashi,et al. Hla Drb4 0101-restricted Immunodominant T Cell Autoepitope of Pyruvate Dehydrogenase Complex in Primary Biliary Cirrhosis: Evidence of Molecular Mimicry in Human Autoimmune Diseases , 1995 .
[22] S. L. Silins,et al. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen , 1995, The Journal of experimental medicine.
[23] J. McCluskey,et al. Cross‐reactive memory T cells for Epstein‐Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex‐bound peptide by T cells and its role in alloreactivity , 1997, European journal of immunology.
[24] P. Doherty,et al. Effector CD4+ and CD8+ T‐cell mechanisms in the control of respiratory virus infections , 1997, Immunological reviews.
[25] V. Brusic,et al. Neural network-based prediction of candidate T-cell epitopes , 1998, Nature Biotechnology.
[26] K. Garcia,et al. Structural basis of T cell recognition. , 1999, Annual review of immunology.
[27] S. Burrows,et al. Direct alloreactivity by human cytotoxic T lymphocytes can Be inhibited by altered peptide ligand antagonism. , 1999, Blood.
[28] S. L. Silins,et al. The influence of antiviral T-cell responses on the alloreactive repertoire. , 1999, Immunology today.
[29] R. Zinkernagel,et al. Immunological Memory , 2006 .
[30] F. Koning,et al. Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[31] L. Moretta,et al. HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[32] M. Menzies,et al. Ex Vivo Profiling of CD8+-T-Cell Responses to Human Cytomegalovirus Reveals Broad and Multispecific Reactivities in Healthy Virus Carriers , 2003, Journal of Virology.
[33] Anajane G. Smith,et al. Ten HLA-DR4 alleles defined by sequence polymorphisms within the DRB1 first domain , 2004, Immunogenetics.
[34] R. Khanna,et al. Cross-recognition of human alloantigen by cytomegalovirus glycoprotein-specific CD4+ cytotoxic T lymphocytes: implications for graft-versus-host disease. , 2005, Blood.
[35] S. Jameson,et al. Central tolerance: learning self-control in the thymus , 2005, Nature Reviews Immunology.
[36] P. Doherty,et al. Structural determinants of T-cell receptor bias in immunity , 2006, Nature Reviews Immunology.
[37] L. K. Ely,et al. T cell allorecognition and MHC restriction--A case of Jekyll and Hyde? , 2008, Molecular immunology.
[38] J. McCluskey,et al. T-cell allorecognition: a case of mistaken identity or déjà vu? , 2008, Trends in immunology.
[39] S. Sainsbury,et al. T cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides. , 2009, Immunity.
[40] L. K. Ely,et al. Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition , 2009, The Journal of experimental medicine.
[41] Anajane G. Smith,et al. Ten HLA-DR 4 alleles defined by sequence polymorphisms within the DRB 1 first domain , 2022 .